Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Medtronic
Federal Trade Commission
Daiichi Sankyo
McKesson
Julphar
Chinese Patent Office
Citi
Dow

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,372,828

« Back to Dashboard

Which drugs does patent 8,372,828 protect, and when does it expire?

Patent 8,372,828 protects PICATO and is included in one NDA.

This patent has twenty-eight patent family members in twenty countries.
Summary for Patent: 8,372,828
Title:Therapeutic compositions
Abstract: Ingenol angelate is a potent anticancer agent, and can be stabilized by dissolving it in an aprotic solvent in the presence of an acidic buffer.
Inventor(s): Brown; Marc Barry (Watford, GB), Crowthers; Michael Edward Donald (Hillsborough, GB), Nazir; Tahir (Isleworth, GB)
Assignee: LEO Laboratories Limited (Dublin, IE)
Application Number:13/563,720
Patent Claim Types:
see list of patent claims
Use; Formulation;

Drugs Protected by US Patent 8,372,828

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Leo Labs PICATO ingenol mebutate GEL;TOPICAL 202833-001 Jan 23, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Leo Labs PICATO ingenol mebutate GEL;TOPICAL 202833-002 Jan 23, 2012 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 8,372,828

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0525680.5Dec 16, 2005

Non-Orange Book US Patents Family Members for Patent 8,372,828

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,278,292 Therapeutic compositions ➤ Sign Up
8,536,163 Therapeutic compositions ➤ Sign Up
9,833,428 Therapeutic compositions ➤ Sign Up
8,716,271 Therapeutic compositions ➤ Sign Up
9,603,822 Therapeutic compositions ➤ Sign Up
9,833,429 Therapeutic compositions ➤ Sign Up
9,820,959 Therapeutic compositions ➤ Sign Up
8,735,375 Therapeutic compositions ➤ Sign Up
8,372,827 Therapeutic compositions ➤ Sign Up
8,377,919 Therapeutic compositions ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,372,828

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 1988877 ➤ Sign Up
Portugal 1988877 ➤ Sign Up
New Zealand 569197 ➤ Sign Up
Norway 20083150 ➤ Sign Up
Mexico 2008007685 ➤ Sign Up
South Korea 101593579 ➤ Sign Up
South Korea 20140088617 ➤ Sign Up
South Korea 101451993 ➤ Sign Up
South Korea 20080092373 ➤ Sign Up
Japan 5709826 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
Daiichi Sankyo
Julphar
Cipla
Fish and Richardson
Express Scripts
Citi
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot